Progressing Pre-Clinical & Translational Applicability of Non-Coding RNAs Towards Clinical Development

Time: 11:30 am
day: Day Two

Details:

  • LncRNA are an attractive new area for oncology therapeutics
  • Antisense oligonucleotides can play a key role in inhibiting lncRNAs
  • First lncRNA ASO identified that is progressing to human clinical trials

Speakers: